Anti-oxidant, mineral, amino acid and botanical factors for the regulation
and promotion of healthy heart function
- Support for healthy heart rate and rhythm
- Supports healthy coronary electrical conduction
- Support of healthy intracellular calcium metabolism
- Coronary vascular and circulation support
- Cardiac mitochondrial energy support
For support of healthy heart function think of UltraCardio. UltraCardio contains
specific antioxidant, mineral, amino acid and botanical factors for the regulation
and promotion of healthy heart function.
Serving size: 3 veggie capsules
Number of servings per container: 30
- Calcium (Aspartate, Citrate/Malate)
75 mg
- Magnesium (Taurate, Aspartate)
200 mg
- Selenium (Aspartate)
100 mcg
- Potassium (Taurate, Aspartate)
200 mg
- Taurine
300 mg
- Polygonum cuspidatum
(20% resveratrols and 10% emodin)
50 mg
- Hawthorne (Crataegus oxycantha leaf extract)
75 mg
- L-Carnitine
200 mg
- CoEnzyme Q10
50 mg
- Alpha R-Lipoic Acid
20 mg
Suggested Dose: As a dietary supplement, take 1 capsule per meal and at bedtime
or as directed by a health care professional.
Read Customer questions and answers about Other Health Concerns in our FAQ.
Calcium along with magnesium and potassium is important for healthy heart muscle including positive support for healthy rate and rhythm. Dietary calcium supports a healthy blood pressure.
Magnesium has potent vasodilator properties and has the ability to displace calcium from the smooth muscle cell surfaces. With magnesium deficiency there is an increased flow of calcium into vascular smooth muscle cells, increasing contractility and potentiated constrictor effects. Supplementation of magnesium may prevent and correct abnormal cardiac rhythm, including toxic rhythms iatrogenically caused by Rx drug medications.
Selenium deficiency may accompany poor heart health. Supplementation may improve heart symptoms in individuals suffering from selenium deficiency.
Potassium deficiency (which may exist despite normal serum levels) is associated with abnormal cardiac rhythm and decreased tolerance to heart medications. Intracellular (RBC) potassium levels are a more accurate means of assessing cellular potassium status. Low potassium status increases the incidence of excessive ventricular heart rates and preventricular contractions.
Taurine affects membrane excitability by normalizing potassium transport across the cardiac muscle cell. Taurine may reduce rhythm abnormalities of the heart.
Polygonum cuspidatum is the natural source of resveratrol a powerful antioxidant that supports healthy coronary artery health.
Hawthorne extracts may have cardiotonic properties due to its content of procyanidin flavonoids. Traditional indications have been for cardiac insufficiency, and mild forms of arrhythmias.
L-Carnitine deficiency may impair heart health. Carnitine supports healthy heart rhythm and strength.
Coenzyme Q10 besides its known antioxidant functions, coenzyme Q10 supports healthy heart mitochondrial function and heart rate and rhythm.
Alpha R-Lipoic Acid is the natural form of alpha lipoic acid. ARLA is more potent and more efficiently utilized than the synthetic racemic mixture ALA (ALRSLA). ARLA enhances myocardial energy production, has antioxidant properties and antioxidant recycling properties.
References:
- Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta-analysis of randomized clinical trials. Ann Intern Med. 124:825-831, 1996.
- Roden DM. Magnesium treatment of ventricular arrhythmias. Am J Cardiol 63(14):43g-46g, 1989.
- Altura BM, Altura BT. Magnesium ions and contraction of vascular smooth muscles: Relationship to some vascular diseases. Fed Proc 40(12):2672-9, 1981.
- DeCarli C et al. Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am J Cardiol 57:956, 1986.
- Cohen L, Kitzes R. Magnesium deficiency and digitalis toxicity. JAMA 251:730, 1984
- Cohen L, Kitzes R. Magnesium sulfate and digitalis-toxic arrhythmias. JAMA 249:2808-10, 1983.
- Kafka H et al. Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Arch Intern Med 147(3):465-69, 1987.
- Nordrehaug J et al. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction.
- Sangiori GB et al. Serum potassium levels, red-blood-cell potassium and alterations of the repolarization phase of electrocardiography in old subjects. Age Ageing 13:309, 1984.
- Ren J, Zhang L, Benishin CG. Parathyroid hypertensives factor inhibits voltage-gated K+ channels in vascular smooth muscle cells. Can J Physiol Pharmacol. 77:860-865, 1999.
- Dychner T, Wester PO. Magnesium and potassium in serum and muscle in relation to disturbances of cardiac rhythm. Magnesium in Health and Disease. Spectrum Publishing Co., pp. 551-7, 1980.
- Lockitch G et al. Cardiomyopathy associated with nonendemic selenium deficiency in Caucasian adolescent. Am J Clin Nutr 52:572-77, 1990.
- Godman IS, Kantrowitz NE. Cardiomyopathy associated with selenium deficiency. Letter. N Engl J Med 305:701, 1982.
- Pace-Asciak CR et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta Mar 31:235(2):207-219, 1995.
- Thompson EB, Aynilian GH, Gora P, Farnworth NR. Preliminary study of potential antiarrhythmic effects of Crataegus monogyna. J Pharm Sci 63(12):1936-7, 1974.
- Tripp ME et al. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable Cardiomyopathy. N Engl J Med 305:385, 1982.
- DiPalma JR et al. Cardiovascular and antiarrhythmic effects of carnitine. Arch Int Pharmacdyn Ther 217(2):246-50, 1975.
- Fujioka T et al. Clinical study of cardiac arrhythmias using a 24-hour continuous electrocardiographic recorder (5th report): Antiarrhythmic action of coenzyme Q10 in diabetics. Tohoku J Exp Med 141(suppl):453-63, 1983.
- Langsjoen PH et al. Effective treatment with coenzyme Q10 of individuals with chronic myocardial disease. Drugs Exp Clin Res 11(8):577-79, 1985.
- Folkers K et al. Biochemical rationale and myocardial tissue data on the effective therapy of Cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci USA 82:901, 1985.
- Zimmer G, Beikler TK, Schneider M, et al. Dose/response curves of lipoic acid R- and S- forms in the working rat heart during reoxygenation: superiority of the R-entantiomer in the enhancement of aortic flow. J Mol Cell Cardiol 27:1895-1903, 1995.
- Hagen RM, Ingersoll RT, Lykkesfeldt J, et al. (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASB J 13:411-418, 1999.
- Werbach MR. Nutritional Influences on Illness: A sourcebook of clinical research, 2nd Ed. Third Line Press. Tarzana, CA. 1993.
- PDR for Herbal Medicines, 1st Ed. Medical Economics Company. Montvale, NJ. 1998.
|
|
Category
